New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care, Gleneagles Hospital Mumbai is pleased to announce the expansion of its Bone Marrow Transplant (BMT) program to include dedicated services for pediatric patients. This initiative aims to provide comprehensive BMT services catering specifically to children, offering renewed hope and advanced treatment options for pediatric hematologic and oncologic conditions.
The addition of Pediatric BMT services builds upon our existing expertise in adult BMT and further underscores our commitment to delivering exceptional healthcare across all age groups.
Dr. Ruchira Misra, a distinguished and dedicated pediatric hematologist-oncologist and transplant physician will spearhead this new program. With her extensive experience and compassionate approach to pediatric care, Dr. Misra is poised to make a significant impact on the lives of young patients and their families.
“We are thrilled to introduce Pediatric Bone Marrow Transplant services at Gleneagles Hospital Mumbai,” said Dr. Ruchira Misra. Pediatric BMTs offer a chance of cure for a number of diseases like relapsed blood cancers, neuroblastomas, thalassemia, sickle cell anemia, Wiskott-Aldrich syndrome, and many more conditions. However, these children require very specialized care during their treatment. Gleneagles Hospital is already renowned for its high standards of care.”
“This expansion represents a pivotal moment for Gleneagles Hospital Mumbai as we broaden our scope to meet the unique healthcare needs of pediatric patients “We are dedicated to providing specialized care and are confident that our pediatric BMT program will make a positive difference in the lives of many families. “Noted by Chief Operating Officer, Gleneagles Healthcare India Dr Vivek Talaulikar .
Corporate Comm India (CCI Newswire)
